These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 5535064

  • 1. The effect of L-dopa treatment on the speech of patients with Parkinson's disease.
    Audelman JU, Hoel RL, Lassman FM.
    Neurology; 1970 Apr; 20(4):410-1. PubMed ID: 5535064
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [New methods for measurement of the tremor and rigidity in patients with Parkinson's disease treated with L-Dopa].
    Paci A, Freddi A, Barba C.
    Riv Neurol; 1973 Apr; 43(1):15-39. PubMed ID: 4698011
    [No Abstract] [Full Text] [Related]

  • 4. [L-dopa effect in Parkinson's syndrome].
    Römer F, Bettag W, Bock WJ.
    Z Allgemeinmed; 1971 Feb 28; 47(6):281-3. PubMed ID: 5571715
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of Parkinson's syndrome with L-dopa].
    Ljung O.
    Lakartidningen; 1972 Jun 07; 69(24):2940-4. PubMed ID: 5037135
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Efficacy and side effects of L-dopa in patients with Parkinson's syndrome].
    Lombardo L.
    Arch Invest Med (Mex); 1973 Jun 07; 4(3):215-24. PubMed ID: 4784173
    [No Abstract] [Full Text] [Related]

  • 12. [Results of psychometic tests in 23 patients with Parkinson's disease after 6 months treatment with L-dopa].
    Barbizet J, Duizabo P, Pasquier M.
    Rev Neurol (Paris); 1972 Aug 07; 127(2):311-3. PubMed ID: 4666638
    [No Abstract] [Full Text] [Related]

  • 13. L-dopa for Parkinson's disease; some limitations in its use.
    Gillen HW.
    Med Trial Tech Q; 1973 Aug 07; 19(4):400-8. PubMed ID: 4710961
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of Parkinson's disease with L-dopa].
    Guglielmi L, Vecchi L.
    Clin Ter; 1970 May 15; 53(3):259-69. PubMed ID: 4917328
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dopa in Parkinson's disease.
    Rosenberg H.
    N Engl J Med; 1969 Mar 27; 280(13):730. PubMed ID: 5766091
    [No Abstract] [Full Text] [Related]

  • 20. The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report.
    Wycis HT.
    Confin Neurol; 1972 Mar 27; 34(2):130-5. PubMed ID: 4666056
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.